Melatonin regulates PARP1 to control the senescence-associated secretory phenotype (SASP) in human fetal lung fibroblast cells

Journal of Pineal Research

Volumn 63, Issue 1, 2017, Pages

  Yu, Songtao ^a   Wang, Xiaojiao ^a   Geng, Peiliang ^a   Tang, Xudong ^a   Xiang, Lisha ^b   Lu, Xin ^a   Li, Jianjun ^a   Ruan, Zhihua ^a   Chen, Jianfang ^a   Xie, Ganfeng ^a   Wang, Zhe ^a   Ou, Juanjuan ^a   Peng, Yuan ^a   Luo, Xi ^a   Zhang, Xuan ^a   Dong, Yan ^a   Pang, Xueli ^a   Miao, Hongming ^a   Chen, Hongshan ^c   Liang, Houjie ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

cellular senescence; histone acetylation; melatonin; PARP1; SASP; TERRA

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; MELATONIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PARP1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; EPIGENETICS; FETUS; GENE CONTROL; GENE INDUCTION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LUNG FIBROBLAST; ONCOGENE; PHENOTYPE; SENESCENCE; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; TELOMERE LENGTH; CELL AGING; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENETICS; LUNG; METABOLISM;

CELL LINE; CELLS, CULTURED; CELLULAR SENESCENCE; FIBROBLASTS; HUMANS; LUNG; MELATONIN; POLY (ADP-RIBOSE) POLYMERASE-1;

EID: 85016424041     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12405     Document Type: Article

References (57)

1. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007;130:223-233.
2. Narita M, Lowe SW. Senescence comes of age. Nat Med. 2005;11:920-922.
3. Childs BG, Durik M, Baker DJ, et al. Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nat Med. 2015;21:1424-1435.
4. Muñoz-Espín D, Serrano M. Cellular senescence: From physiology to pathology. Nat Rev Mol Cell Biol. 2014;15:482-496.
5. Tchkonia T, Zhu Y, Van Deursen J, et al. Cellular senescence and the senescent secretory phenotype. J Clin Invest. 2013;123:966-972.
6. Pérez-Mancera PA, Young ARJ, Narita M. Inside and out: The activities of senescence in cancer. Nat Rev Cancer. 2014;14:547-558.
7. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol. 2011;192:547-556.
8. Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479:232-236.
9. Schmitt CA. Cellular senescence and cancer treatment. Biochim Biophys Acta. 2007;1775:5-20.
10. Coppé J-P, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:2853-2868.
11. Novakova Z, Hubackova S, Kosar M, et al. Cytokine expression and signaling in drug-induced cellular senescence. Oncogene. 2010;29:273-284.
12. Di Micco R, Fumagalli M, Cicalese A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006;444:638-642.
13. Chen H, Ruiz PD, Mchimpson WM, et al. MacroH2A1 and ATM play opposing roles in paracrine senescence and the senescence-associated secretory phenotype. Mol Cell. 2015;59:719-731.
14. Rodier F, Coppé J-P, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009;11:973-979.
15. Takahashi A, Imai Y, Yamakoshi K, et al. DNA damage signaling triggers degradation of histone methyltransferases through APC/C Cdh1 in senescent cells. Mol Cell. 2012;45:123-131.
16. Rouleau M, Patel A, Hendzel MJ, et al. PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 2010;10:293-301.
17. Kraus WL, Hottiger MO. PARP-1 and gene regulation: Progress and puzzles. Mol Aspects Med. 2013;34:1109-1123.
18. Timinszky G, Till S, Hassa PO, et al. A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat Struct Mol Biol. 2009;16:923-929.
19. Chen H, Ruiz PD, Novikov L, et al. MacroH2A1.1 and PARP-1 cooperate to regulate transcription by promoting CBP-mediated H2B acetylation. Nat Struct Mol Biol. 2014;21:981-989.
20. Hardeland R. Melatonin and the theories of aging: A critical appraisal of melatonin's role in antiaging mechanisms. J Pineal Res. 2013;55:325-356.
21. Manchester LC, Coto-Montes A, Boga JA, et al. Melatonin: An ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 2015;59:403-419.
22. Yang Y, Sun Y, Yi W, et al. A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. J Pineal Res. 2014;57:357-366.
23. Song N, Kim AJ, Kim HJ, et al. Melatonin suppresses doxorubicin-induced premature senescence of A549 lung cancer cells by ameliorating mitochondrial dysfunction. J Pineal Res. 2012;53:335-343.
24. Zhou L, Chen X, Liu T, et al. Melatonin reverses H2O2-induced premature senescence in mesenchymal stem cells via the SIRT1-dependent pathway. J Pineal Res. 2015;59:190-205.
25. Navab R, Strumpf D, Bandarchi B, et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci USA. 2011;26(108):7160-7165.
26. Novikov L, Park JW, Chen H, et al. QKI-mediated alternative splicing of the histone variant macroH2A1 regulates cancer cell proliferation. Mol Cell Biol. 2011;31:4244-4255.
27. Zhu H, Ren S, Bitler BG, et al. SPOP E3 ubiquitin ligase adaptor promotes cellular senescence by degrading the SENP7 deSUMOylase. Cell Rep. 2015;13:1183-1193.
28. Deng Z, Norseen J, Wiedmer A, et al. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell. 2009;35:403-413.
29. Herranz N, Gallage S, Mellone M, et al. mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol. 2015;17:1205-1217.
30. Acosta JC, Banito A, Wuestefeld T, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15:978-990.
31. Chien Y, Scuoppo C, Wang X, et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 2011;25:2125-2136.
32. Matos L, Gouvela AM, Almeida H. ER stress response in human cellular models of senescence. J Gerontol A Biol Sci Med Sci. 2015;70:924-935.
33. Higa A, Chevet E. Redox signaling loops in the unfolded protein response. Cell Signal. 2012;24:1548-1555.
34. Wang Z, Deng Z, Dahmane N, et al. Telomeric repeat-containing RNA (TERRA) constitutes a nucleoprotein component of extracellular inflammatory exosomes. Proc Natl Acad Sci USA. 2015;112:6293-6300.
35. Swindall AF, Stanley JA, Yang ES. PARP-1: Friend or foe of DNA damage and repair in tumorigenesis?. Cancers (Basel). 2013;5:943-958.
36. Fernández A, Ordóñez R, Reiter RJ, et al. Melatonin and endoplasmic reticulum stress: Relation to autophagy and apoptosis. J Pineal Res. 2015;59:292-307.
37. De Luxán-Delgado B, Potes Y, Rubio-González A, et al. Melatonin reduces endoplasmic reticulum stress and autophagy in liver of leptin-deficient mice. J Pineal Res. 2016;61:108-123.
38. Kang C, Xu Q, Martin TD, et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science. 2015;349:aaa5612.
39. Deng Y, Chan SS, Chang S. Telomere dysfunction and tumour suppression: The senescence connection. Nat Rev Cancer. 2008;8:450-458.
40. Kung JIY, Colognori D, Lee JT. Long noncoding RNAs: Past, present, and future. Genetics. 2013;193:651-669.
41. Gramma Tikakis I, Panda AC, Abdelmohsen K, et al. Long noncoding RNAs (lncRNAs) and the molecular hallmarks of aging. Aging. 2014;6:992-1009.
42. Azzalin CM, Lingner J. Telomere functions grounding on TERRA firma. Trends Cell Biol. 2015;25:29-36.
43. Luo H, Sun Y, Wei G, et al. Functional characterization of long noncoding RNA lnc_bc060912 in human lung carcinoma cells. Biochemistry. 2015;54:2895-2902.
44. Cai B, Ma W, Bi C, et al. Long noncoding RNA H19 mediates melatonin inhibition of premature senescence of c-kit+ cardiac progenitor cells by promoting miR-675. J Pineal Res. 2016;61:82-95.
45. Ogino H, Nozaki T, Gunji A, et al. Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells. BMC Genom. 2007;8:41.
46. Rai TS, Cole JJ, Nelson DM, et al. HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of Neoplasia. Genes Dev. 2014;28:2712-2725.
47. O'donnell A, Yang S-H, Sharrocks AD. PARP1 orchestrates variant histone exchange in signal-mediated transcriptional activation. EMBO Rep. 2013;14:1084-1091.
48. Weaver AN, Yang ES. Beyond DNA repair: Additional functions of PARP-1 in cancer. Front Oncol. 2013;3:1-11.
49. Fan C, Pan Y, Yang Y, et al. HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways. J Pineal Res. 2015;59:321-333.
50. Chen X, Hao A, Li X, et al. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH-STAT3 signaling axis. J Pineal Res. 2016;61:208-217.
51. Liu F, Wang L, Perna F, et al. Beyond transcription factors: How oncogenic signalling reshapes the epigenetic landscape. Nat Rev Cancer. 2016;16:359-372.
52. Han P, Chang C-P. Long non-coding RNA and chromatin remodeling. RNA Biol. 2015;12:1094-1098.
53. Han P, Li W, Lin C-H, et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature. 2014;514:102-106.
54. Guetg C, Scheifele F, Rosenthal F, et al. Inheritance of silent rDNA chromatin is mediated by PARP1 via noncoding RNA. Mol Cell. 2012;45:790-800.
55. Fischer TW, Zmijewski MA, Wortsman J, et al. Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res. 2008;44:397-407.
56. Clayton-Chubb DI, Lange PW. Moderate dose melatonin for the abatement and treatment of delirium in elderly general medical inpatients: Study protocol of a placebo controlled, randomised, double blind trial. BMC Geriatr. 2016;29:16.
57. Gubin DG, Gubin GD, Gapon LI, et al. Daily melatonin administration attenuates age-dependent disturbances of cardiovascular rhythms. Curr Aging Sci. 2016;9:5-13.